Slide 1: Cochlear Limited 2013 Annual General Meeting
For personal use only Cochlear Limited 2013 Annual General Meeting Exchange Square Auditorium Australian Securities Exchange 20 Bridge Street Sydney NSW 2000 Tuesday 15th October 2013 1
Slide 2: Chairman and Company Secretary
Mr Rick Holliday-Smith - Chairman For personal use only Mr Neville Mitchell – Company Secretary 2
Slide 3: CEO/President and Director
Dr Chris Roberts – Chief Executive Officer / President For personal use only Prof Ed Byrne AO - Director 3
Slide 4: Directors
Mrs Yasmin Allen - Director For personal use only Mr Paul Bell - Director 4
Slide 5: Directors
Mr Donal O’Dwyer - Director For personal use only Mr Andy Denver - Director 5
Slide 6: Chairman's Address
For personal use only Chairman’s Address Rick Holliday-Smith Cochlear Annual General Meeting 2013 6
Slide 7: CEO's Address: Cochlear Overview
For personal use only CEO’s Address Chris Roberts Cochlear Annual General Meeting 2013 Cochlear Overview • Cochlear Limited (ASX:COH) is the global leader in implantable hearing devices e.g. cochlear implants • ~ 2,700 employees • Direct operations in 20+ countries, and products sold in 100+ countri
Slide 8: Hearing Loss is a Major Public Health Problem
Hearing Loss is a Major Public Health Problem For personal use only • Hearing is critically important in developing and maintaining optimal cognitive, physical and social function across the lifespan • Implantable devices, such as cochlear implants and bone conduction implants provide safe, cost eff
Slide 9: A Multi-disciplinary Environment as Catalyst for Global Collaboration
A Multi-disciplinary Environment as Catalyst for Global Collaboration For personal use only Research & Development Clinical support Electrical engineering Neuroscience Software engineering Neuropsychology Speech pathology Clinical psychology Cochlear Macquarie University Language science Hospital Co
Slide 10: Cochlear Nucleus – Simply Smarter
Cochlear™ Nucleus® 6 – Simply Smarter For personal use only • SmartSound® iQ • Smallest processor • Integrated Hybrid • Wireless connectivity • Water resistant BTE • Data logging Cochlear Nucleus 6 – Update on Release 1 • Regulatory approval obtained for Europe (CE Mark), for USA Music Speech in Noi
Slide 11: Cochlear Hybrid Implant System
Cochlear Hybrid Implant System For personal use only • An original PMA has been filed with FDA (USA) for regulatory approval of a hybrid cochlear implant system • Combines electrical stimulation for higher frequencies (speech intelligibility) and acoustic amplification for lower frequencies • Expand
Slide 12: Cochlear Baha DermaLock and Baha 4
Cochlear Baha DermaLock™ For personal use only DermaLock™ TiOblast™ It’s all in the surface Cochlear Baha 4 Baha 4 Sound Processor Smarter hearing – wireless freedom Baha 4 Connect System Baha 4 Attract System with DermaLock Invisible link to better hearing Proven hearing performance with soft tissu
Slide 13: Acoustic Implants
For personal use only Camille Video Acoustic Implants • Cochlear Codacs Implant System has received CE mark – Direct acoustic cochlear stimulator – First orders received – First surgery planned for October 2013 • Carina and MET implants have been returned to market, and surgeries underway Codacs Imp
Slide 14: In Summary
In Summary For personal use only • Hearing loss is an under recognised public health problem • Cochlear has suite of implantable devices for hearing impaired • Key new products: – Nucleus 6 – Hybrid (requires PMA approval) – Baha 4 – Baha Attract – Acoustic implants, e.g. Codacs • Creating momentum
Slide 15: Business of the Meeting
For personal use only Cochlear Limited 2013 Annual General Meeting Business of the Meeting 15
Slide 16: Resolution 1: Financial and other reports
Resolution No. 1 For personal use only Financial and other reports To receive and consider the Company’s Financial Report, Directors’ Report and Auditor’s Report in respect of the financial year ended 30 June 2013 and to consider and, if thought fit, to pass the following resolution: 1.1 “THAT the C
Slide 17: Resolution 2: Remuneration Report
Resolution No. 2 For personal use only Remuneration Report To consider and, if thought fit, to pass the following non-binding resolution: 2.1 “THAT the Remuneration Report be adopted” Resolution No. 2 Remuneration Report This resolution will be decided on a poll For Against Open Direct Votes 1.58% 0
Slide 18: Resolution 3: Re-election and election of directors
Resolution No. 3 For personal use only Re-election and election of directors To consider and, if thought fit, to pass the following resolution as an ordinary resolution: Resolution No. 3.1 Re-election of directors 3.1 “THAT Mr Donal O’Dwyer, being a director who is retiring by rotation in accordance
Slide 19: Resolution 3.1: Re-election of Mr Donal O'Dwyer
Resolution No. 3.1 For personal use only Re-election of directors – Mr Donal O’Dwyer This resolution will be decided on a poll For Against Open Direct Votes 3.52% 0.22% - 1,148,576 72,532 Proxy Votes 94.4% 0.64% 1.21% 30,767,139 209,744 393,414 Total 97.92% 0.87% 1.21% 31,915,715 282,276 393,414 Res
Slide 20: Resolution 3.2: Re-election of Mrs Yasmin Allen
Resolution No. 3.2 For personal use only Re-election of directors 3.1 “THAT Mrs Yasmin Allen, being a director who is retiring by rotation in accordance with the Company’s Constitution and who, being eligible, offers herself for re-election as a director of the Company, be re-elected as a director o
Slide 21: Resolution 4: Securities to CEO under Executive Incentive Plan
Resolution No. 4 For personal use only Approval of issue, allocation or transfer of securities to the CEO/President under the Cochlear Executive Incentive Plan (CEIP) To consider and, if thought fit, to pass the following resolution as an ordinary resolution: 4.1 “THAT approval be given to: a) The g
Slide 22: Collection of Poll Cards / Close of Meeting
Collection of Poll Cards For personal use only Please complete and submit your poll card Close of Meeting 22
Slide 23: For personal use only
For personal use only 23